Reveal for Lung Cancer analyzes existing EHR data to identify patients who show a higher statistical risk of certain respiratory illnesses, including cancers of the lung or trachea.
Lucem Health featured as one of the "Top 10 AI Titans Empowering Family Offices in the Age of AI: Investment Trends and Opportunities".
Our CEO, Sean Cassidy, was recently interviewed by HIStalk on the difficulties for health systems integrating AI, helping health system executives develop a plan for AI, the nuance between AI models and AI solutions, and more.
We're thrilled to share this informative discussion between DocWire News and our CEO, Sean Cassidy.
Lucem Health CEO, Sean Cassidy, was interviewed by Claire Rychlewski at Axios during the HIMSS23 Conference in Chicago, discussing the latest about our upcoming Series A funding extension.
SOC 2 Type II certification reflects our commitment to security, confidentiality, and integrity in AI-powered healthcare solutions.
Lucem Health™ today announced the availability of its new early disease detection solutions, Lucem Health Reveal.
Mayo Clinic and Commure, a General Catalyst portfolio health care [...]
Lucem Health helps healthcare providers accelerate disease detection and treatment using practical, responsible AI—so they can improve patients’ lives and increase the clinical and financial yield from today’s scarce care delivery resources.
Navigation
Navigation
Solutions
Early Disease Detection
Clinical Decision Support